Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study (Q83676605)
Jump to navigation
Jump to search
scientific article published on 08 November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study |
scientific article published on 08 November 2010 |
Statements
Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study (English)
Mélanie Gauthier
David Malka
Christophe Locher
Jean-Marc Gornet
Anne Thirot-Bidault
Julien Taïeb
Franck Bonnetain
Thomas Aparicio
Association des Gastro Entérologues Oncologues